Publication: Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies
dc.contributor.author | KORKMAZ, PINAR | |
dc.contributor.author | Demirturk, Nese | |
dc.contributor.author | Batirel, Ayse | |
dc.contributor.author | Tulek, Necla | |
dc.contributor.author | Ozguler, Muge | |
dc.contributor.author | Harman, Rezan | |
dc.contributor.author | Cinar, Gule | |
dc.contributor.author | TOKA, ONUR | |
dc.contributor.author | Yoruk, Gulsen | |
dc.contributor.author | Ataman-Hatipoglu, Cigdem | |
dc.contributor.author | Sarigul, Figen | |
dc.contributor.author | SIRMATEL, FATMA | |
dc.contributor.author | Imre, Ayfer | |
dc.contributor.author | MISTANOĞLU ÖZATAĞ, DURU | |
dc.contributor.author | KARAKEÇİLİ, FARUK | |
dc.contributor.author | URAL, ONUR | |
dc.contributor.author | SÜMER, ŞUA | |
dc.contributor.author | Aktug-Demir, Nazlim | |
dc.contributor.author | Kadanali, Ayten | |
dc.contributor.author | Comoglu, Senol | |
dc.contributor.author | Ucer, Sengul | |
dc.contributor.author | Saltoglu, Nese | |
dc.contributor.author | Gunal, Ozgur | |
dc.contributor.author | Ozkaya, Hacer Deniz | |
dc.contributor.author | Yenilmez, Ercan | |
dc.contributor.author | Cetinkaya, Riza Aytac | |
dc.contributor.author | Yuksel, Esma | |
dc.contributor.author | HAKYEMEZ, İSMAİL NECATİ | |
dc.contributor.author | MERİÇ KOÇ, MELİHA | |
dc.contributor.author | Tuncer-Ertem, Gunay | |
dc.contributor.author | Bestepe-Dursun, Zehra | |
dc.contributor.author | Celik, Ilhami | |
dc.contributor.author | YILMAZ, EMEL | |
dc.contributor.author | Evik, Guliz | |
dc.contributor.author | Kaya, Ali | |
dc.contributor.author | Suer, Kaya | |
dc.contributor.institutionauthor | HAKYEMEZ, İSMAİL NECATİ | |
dc.contributor.institutionauthor | MERİÇ KOÇ, MELİHA | |
dc.date.accessioned | 2020-10-21T20:28:20Z | |
dc.date.available | 2020-10-21T20:28:20Z | |
dc.date.issued | 2019-12-01T00:00:00Z | |
dc.description.abstract | Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment. | |
dc.identifier.citation | KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., Cinar G., TOKA O., Yoruk G., Ataman-Hatipoglu C., et al., -Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies-, KLIMIK JOURNAL, cilt.32, ss.265-274, 2019 | |
dc.identifier.doi | 10.5152/kd.2019.73 | |
dc.identifier.scopus | 85077860443 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12645/23478 | |
dc.identifier.wos | WOS:000511173500009 | |
dc.title | Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | 1c848444-bc56-431d-ada5-7b9e4234eb65 | |
local.indexed.at | WOS | |
local.indexed.at | Scopus | |
local.publication.goal | 03 - Sağlık ve Kaliteli Yaşam | |
local.publication.isinternational | 1 | |
relation.isAuthorOfPublication | 34a9d344-3a58-4f83-864a-5a5c664557bd | |
relation.isAuthorOfPublication | dd6ca7f4-a1a6-4c91-9a61-e55f1118b6d9 | |
relation.isAuthorOfPublication.latestForDiscovery | 34a9d344-3a58-4f83-864a-5a5c664557bd | |
relation.isGoalOfPublication | 9c198c48-b603-4e2f-8366-04edcfc1224c | |
relation.isGoalOfPublication.latestForDiscovery | 9c198c48-b603-4e2f-8366-04edcfc1224c |